Page last updated: 2024-10-29

amrinone and MODS

amrinone has been researched along with MODS in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"This case report details the pharmacokinetic adjustments of an amrinone infusion in a paediatric patient who developed multiorgan system failure with anuric renal failure and was prescribed continuous arteriovenous haemofiltration."1.29Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone. ( Azin, S; Corddry, D; Lawless, S; Restaino, I, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lawless, S1
Restaino, I1
Azin, S1
Corddry, D1

Other Studies

1 other study available for amrinone and MODS

ArticleYear
Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone.
    Clinical pharmacokinetics, 1993, Volume: 25, Issue:1

    Topics: Acute Kidney Injury; Amrinone; Child; Female; Half-Life; Hemofiltration; Humans; Metabolic Clearance

1993